Your board asks what to do with $100M of excess cash. You have 60 seconds to answer. Five years later, that decision will explain better than any budget whether you were a CFO or an administrator.
Capital allocation is the most strategic work a CFO does and the least taught in business schools. Most confuse "being conservative" with "doing nothing," "being aggressive" with "reinvesting everything," and "returning to shareholders" with "the safe option."
There's a framework for getting this decision right. It doesn't tell you what the right answer is — it tells you what questions to ask and how to defend whatever you decide in front of the board. That's what separates capital allocation from "what feels good."
By the end of this module you'll have it down. Let's go.
The board asks: "we have $100M of extra cash. What do we do?" What's your first answer?
In plain language
Before the mechanics, the four basic questions.
Why do this at all?
Because every dollar your company generates has five possible uses. Choosing well among them over 10 years determines whether the company doubles or stalls. Brilliant operations can be destroyed by mediocre capital allocation. Operationally average companies can become extraordinary with excellent capital allocation.
Who uses it?
CFO leads. Board approves — one of the few pure strategic topics the board actually decides, not just reviews. CFO reports to shareholders in annual reports. In family businesses, the family discusses it.
When does it show up?
Formally, once a year in strategic review. Tactically, every time material excess cash appears (capital round, partial exit, extraordinary year). Defensively, every time there's financial stress — allocation changes a lot in hard scenarios.
What if we skip it?
You decide by inertia. You reinvest "because we've always reinvested," or return "because shareholders ask." Without process, the decision reflects the political pressure of the moment, not the best use of capital. In 5 years, the track record judges you without mercy.
Five buckets, one decision
Andina S.A. closed an extraordinary year. Excess cash: $100M. The CEO wants aggressive reinvestment. The finance director wants to pay down debt. A new board member from private equity asks for buybacks. The family shareholders want dividends. Four voices, four interests, no comparison between them.
This is exactly the problem a capital-allocation framework solves. It doesn't vote the loudest voice; it compares options against explicit criteria. The five options are always the same: core reinvestment, M&A, debt paydown, return to shareholders, or hold cash for optionality.
The visual below lets you play with the $100M across the five buckets. Watch the weighted IRR, strategic fit, and board comfort change in real time. That's exactly the board conversation — but now with a shared frame instead of four crossed opinions.
The five buckets, live
Five buckets. Each with its own expected IRR and strategic weight. There is no universally correct allocation — but there are allocations your board can defend and others it can't.
Try the presets: aggressive growth, balanced, defensive, return-to-shareholders. Watch the metrics change. Then move sliders manually — where is your natural allocation? Is it defensible?
Interactive visual
You have $100M to allocate. Where does it go?
Move the sliders. The sum is always 100%. Watch how weighted IRR and strategic fit change — two different questions, and most CFOs only look at one.
Weighted IRR
12.6%
Strategic fit
6.5/10
Board comfort
6.8/10
Preset
Reinvest in core
Expected IRR: 18% · Strategic score: 9/10
40%
Capex, working capital, R&D in existing business. Typically the highest-confidence return because you know the business.
M&A
Expected IRR: 14% · Strategic score: 7/10
15%
Acquire growth or capability. Highest variance — when it works, biggest return; when it fails, biggest write-off.
Pay down debt
Expected IRR: 7% · Strategic score: 4/10
15%
Risk-free return = cost of debt after tax. Boring but bulletproof — and makes you safer when stress shows up.
Returns to shareholders
Expected IRR: 9% · Strategic score: 5/10
20%
Dividends or buybacks. The right answer when you cannot beat shareholders' alternative use of the money. Easy to do badly.
Hold (optionality)
Expected IRR: 4% · Strategic score: 3/10
10%
Cash gives you optionality — the ability to act when others can't. Real return is low; the value is in the option.
What you are seeing
There's no universally right allocation. There's a right allocation for your company today, given your market position, your balance sheet, and board confidence. But three things are true: (1) if everything goes to "reinvest," you're assuming your core business is the best investment that exists — doubt that. (2) If everything goes to "return," you're saying you have no better ideas than shareholders' alternatives — doubt that too. (3) Capital allocation is the most visible output of CFO quality. You'll be judged on this in 5 years, not on the quarterly close.
Three readings of the visual that matter more than the number: (1) Weighted IRR tells you what return to expect from your mix. If it's 8%, you're near cost of capital — you're scraping by. If it's 15%+, you're capturing value. (2) Strategic fit tells you if the mix aligns with the business direction. A growth company with 50% on debt paydown has a low score even if IRR is decent. (3) Board comfort rewards diversification. A 100% allocation in one bucket is efficient but risky — boards rarely approve it.
The goal is not to maximize one of the three. It's to find the point where all three are "fine." If all three are high, the board signs. If one is low, you defend why.
The mechanics: how to build a defendable proposal
- Define cost of capital first. WACC — the hurdle rate below which any investment destroys value. Without this, you can't evaluate anything. That's module 6.2.
- Estimate expected IRR per bucket, not per project. Core reinvestment ≈ historical return adjusted for maturity (usually 15-25%). M&A ≈ 10-15% after credible synergies. Debt ≈ after-tax debt rate (4-8%). Buyback ≈ market expected return (8-10%). Cash ≈ risk-free rate (3-5%).
- Apply risk adjustment, not just central IRR. M&A with expected 15% IRR but high volatility may be worth less than reinvestment with 12% IRR and low volatility. Boards think in distributions, not points.
- Tie allocation to business phase. Growth-market company: high weight on reinvestment and M&A. Mature, no growth opportunities: high weight on returns. Stressed balance: high weight on debt. Framework is the same; weights change.
- Report realized vs planned allocation every year. "We planned 40% reinvestment, 20% M&A; we executed 50% reinvestment, 10% M&A because opportunity X appeared." Without reporting, no accountability — and without accountability, no learning.
- Defend what you DIDN'T do. "We didn't buy back because price was high vs our DCF." "We didn't pay more debt because cost is low and we want flexibility for M&A." Allocation without defense is allocation without thought.
- Incumbency bias. Assuming the current business is the best investment. Comfortable and almost always false. Mature businesses have declining marginal IRR — the first 10% of capex is excellent, the last 10% is ruinous.
- M&A as synthetic growth. When the core business doesn't grow, buying companies is tempting. Most destroys value — not from bad selection, but because promised synergies never materialize at the expected pace. M&A only creates value when the buyer has a specific advantage the seller doesn't.
- Buyback "because the stock is cheap." The stock is cheap vs what? If vs your own internal DCF, then there's a case. If vs the last-12-month average, the case is vanity. Buffett set the standard: "I buy back only when price < intrinsic value with margin of safety."
- Practical rule: if your capital-allocation proposal generates instant consensus in the board, it's probably badly thought through. Good allocation forces real discussion because it implies saying no to something someone defends.
Adversarial check
Adversarial check
1.The CEO tells you: "we have $50M, let's reinvest all of it expanding the plant — projected IRR is 22%." What do you do?
2.A new board member says: "we should buy back aggressively, the stock is 25% below last year's peak." How do you respond?
3.Your company has had cash growing for 3 years in the operating account at 4%. The board has never made a formal allocation decision. What do you argue?
Exit checklist
Suggested re-review: annual, with the board strategic review. Every time material excess cash appears (>10% of capital base), before making any decision.
Optional
Go deeper
Sources and books to dig into the original material